DreamCIS, Inc. (KOSDAQ: 223250)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,870.00
-90.00 (-3.04%)
Dec 20, 2024, 9:00 AM KST
-2.71%
Market Cap 68.30B
Revenue (ttm) 56.88B
Net Income (ttm) 4.67B
Shares Out 23.80M
EPS (ttm) 193.86
PE Ratio 14.80
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 130,604
Open 2,935.00
Previous Close 2,960.00
Day's Range 2,870.00 - 2,980.00
52-Week Range 2,610.00 - 5,390.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 18, 2025

About DreamCIS

DreamCIS, Inc. provides clinical research services in South Korea. It offers clinical development services; biostatic, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headquartered in Seoul, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2000
Employees 366
Stock Exchange KOSDAQ
Ticker Symbol 223250
Full Company Profile

Financial Performance

In 2023, DreamCIS's revenue was 47.84 billion, an increase of 23.08% compared to the previous year's 38.87 billion. Earnings were 3.74 billion, a decrease of -15.13%.

Financial Statements

News

There is no news available yet.